Home
NICE Guidance
Conditions and diseases
Mental health and behavioural conditions
Attention deficit disorder
Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents
Technology appraisal guidance [TA98]
Published date:
22 March 2006
Guidance
This guidance has been updated and replaced by
NICE guideline NG87
.